Cartesian Therapeutics, Inc.

Cartesian Therapeutics, Inc. financial statements

Cartesian Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 2.8M10-K
Net income−USD 130.3M10-K
Cash and equivalentsUSD 125.14M10-Q
Total debtUSD 010-Q

Cartesian Therapeutics, Inc. financials on 6ix · Cartesian Therapeutics, Inc. on 6ix